Executive SummaryShares are 3x forward earnings (2021), after dilution
Earnings could surprise on the upside if more contracts are signed
$6.6 million of sales next year is 500,000 patients (mostly in Mexico)
The growth after Mexico could come from any country
The numbers are higher than the last forecast
The numbers can be significantly higher if more deals are signed